3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Splenomegaly
1
Primary Myelofibrosis
1
Neoplasm Metastasis
1
Melanoma
1
Leukemia
1
Epidermolysis Bullosa Dystrophica
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Anemia
1
Adenocarcinoma
1
Interventions
ON 01910
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Epidermolysis Bullosa Dystrophica
×
ON 01910
×
Clear all
NCT03786237
2026-02-24
Rigosertib for RDEB-SCC
Salzburger Landeskliniken
Phase 1/2
Completed
2 enrolled